CLINICAL_TRIALS
trial_result
· 2023-10-27
Clinical Trial Update: Aspirin for Exercise in Multiple Sclerosis (ASPIRE) [Phase 3]
Summary
Phase 3 clinical trial ASPIRE evaluating aspirin for exercise benefits in multiple sclerosis has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2023-10-27